BLACKSBURG, Va. – Virginia Tech has been awarded a $300,000 research grant that will be used for metabolic disease research.
Congressman Morgan Griffith announced the HHS awarded the grant for allergy, immunology and transplantation research related to Clostridioides difficile (C. difficile) infection. This infection causes inflammation of the colon, diarrhea and colitis.
Recommended Videos
Headlines - 8 p.m.
Have the day's biggest stories arrive in your inbox every day at 8 p.m.
“C. difficile is a germ that affects the colon and can cause serious illness. This grant for $300,000 helps Virginia Tech explore treatments for harmful metabolic disease,” Congressman Griffith said.
Duncan Weigand joined WSLS 10’s digital team in June 2024, weeks after graduating from Virginia Tech with a bachelor’s in communication studying multimedia journalism and a cognate in marketing.